BeStock  
Stocks › Biotechnology › TARS

Tarsus Pharmaceuticals TARS

US equityMarket cap rank #2295Biotechnology
$73.01 −$4.66 (-6.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $71.00 -2.75%
Open$77.09
Prev close$77.67
Day range$72.57 – $78.11
Volume706.8K
Market cap$3.60B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

TARS at a glance

Tarsus Pharmaceuticals stock (TARS) sits at $73.01, down 6.00% today. The business is worth $3.60B in the market, good for #2295 of 3753 on our coverage list.

Over a full year the shares have ranged across $53.89 to $91.53, which puts the current price roughly 51% of the way up that band. Holders are behind 8.3% over twelve months, but up 0.3% across the last three months.

Price is below the 50-day average ($74.09) but above the 200-day ($68.27); RSI is 48, and the last 30 sessions moved at roughly 49% annualized volatility.

Revenue for the quarter ended Sep 2026 was $194.57M, up 63.9% from a year earlier, and a net loss of $668.33M.

8 analysts follow the stock and the average call is "buy". The mean target, $105.57, sits 44.6% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$71.01 / $73.37
Average price today$73.83
Volume706.8KAvg (90d) 851.1K
Turnover$52.18M
Turnover rate1.74%of shares outstanding
Volume ratio1.10vs. recent average pace
Day amplitude7.13%
Market cap$3.60B
Float market cap$2.97B
Shares outstanding40.67M
EPS (TTM)-$1.59
P/B34.60
Book value / share$2.11
Net profit (TTM)-$78.40M
Net assets$104.03M
30-day volatility48.8%annualized
Avg daily range (ATR)5.94%of price, 14 days
Max drawdown (1y)-32.0%-19.6% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

C
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

8 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 55.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability24.8
Momentum59.7
Financial health55.6
Analyst view77.1

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$105.57+44.6% vs. current price
Consensus ratingBuy8 analysts covering
Morningstar fair value$69.36Price is above fair value

Wall Street’s average 12-month target is $105.57, 44.6% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $69.36, so shares trade 5.3% above that estimate. On earnings multiple, it sits in the 90th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-6.0%
1 week
-9.1%
1 month
+1.3%
3 months
+0.3%
6 months
+17.3%
Year to date
-10.8%
1 year
-8.3%
Day range
$72.57$78.11
52-week range
$53.89$91.53

Technical signals

Full technicals →
Trend readLeaning bearish

3 bullish · 4 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-1.0%Bearish
Price vs 50-day average-1.5%Bearish
Price vs 200-day average+6.9%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)47.7Bearish
MACD (12,26,9)1.05Bullish
Bollinger band position45%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How TARS ranks on BeStock

Market value#2286 of 3734
Closeness to 52-week high#1494 of 3724
Dollar volume today#1393 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

TARS is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on TARS.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on TARS

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

TARS stock: common questions

What is TARS's latest share price?

$73.01 is the latest print for TARS, a move of -6.00% against yesterday's close of $77.67. Today's low and high so far: $72.57 and $78.11.

How large is Tarsus Pharmaceuticals by market value?

Equity value comes to $3.60B at the current price. By that measure it is number 2295 of the 3753 names in our coverage.

Is TARS near its 52-week high or low?

The year's floor is $53.89 and the ceiling $91.53. Shares are 20.2% away from that ceiling.

Does Tarsus Pharmaceuticals pay a dividend?

Our data shows no dividend paid by Tarsus Pharmaceuticals over the trailing twelve months.

Is TARS rated a buy by Wall Street?

Of 8 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $105.57, with the most cautious at $97.00 and the most optimistic at $116.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on TARS.

Sign in to join the discussion.

Scroll to Top